Skip to main content
. 2023 Jul 10;13:1201599. doi: 10.3389/fonc.2023.1201599

Figure 3.

Figure 3

Gastrointestinal toxicity to selpercatinib; very light small bowel thickening was present in June 2022, when the patient started to refer abdominal pain (A, D). In October 2022 (B, E), important bowel wall thickening, mesenteric congestion, and stranding are shown. Complete resolution of the radiological pathological findings in February 2023 is depicted in (C, F).